P.P.Tradelink

Tirzepatide Injection is a prescription medication used to improve blood sugar control in adults with type 2 diabetes. It combines dual-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists to enhance insulin secretion, reduce appetite, and promote weight loss. Administered once weekly via subcutaneous injection, it is designed to complement diet and exercise for optimal diabetes management.

The amount of Takfa 0.5 Capsule you take and how often you take it depends on the type of transplant you have, your body weight, and what other medicines you are taking. Follow your doctor’s instructions carefully. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Take this medicine regularly to get the maximum benefit and keep taking it, even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ.

Takfa 0.5 Capsule has many potential side effects. It can cause or worsen diabetes and kidney problems. These need urgent medical attention. Other common side effects include tremor, infections, high blood pressure, headache, and insomnia. If the side effects do not go away or get worse, tell your doctor. Takfa 0.5 Capsule lowers your immune system making you susceptible to catching more infections than usual.

Before taking this medicine, tell your doctor if you have kidney, liver, or heart problems, diabetes, or high blood pressure. Also let your doctor know what other medications you are taking, especially for infections, pain, and arthritis. These and others may affect, or be affected by, this medicine. You should limit your exposure to the sun and UV (ultraviolet) light while taking it because immunosuppressants could increase your risk of skin cancer.

Both men and women using this medicine should use effective birth control to prevent pregnancy. This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed. Before and during treatment you will need frequent medical tests to monitor your progress, and your blood pressure will need to be checked often.

• Atopic dermatitis
• Prevention of organ rejection in transplant patients
• Rheumatoid arthritis
• Nephrotic syndrome
• Psoriasis
• Bone marrow transplantation
• Uveitis

• Kidney damage
• High blood pressure
• Increased glucose level in blood
• Insomnia (difficulty in sleeping)
• Tremors
• Headache
• Abnormal liver function tests
• Infection

Fulvenat Fulerscent Injection is a prescription medication used for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It works by blocking estrogen receptors, slowing the growth of cancer cells. Administered via intramuscular injection, Fulvenat offers a targeted approach to managing advanced breast cancer, enhancing patient outcomes with its potent anti-estrogenic effects.

• Type 2 diabetes mellitus

• Constipation
• Decreased appetite
• Diarrhea
• Nausea
• Vomiting
• Abdominal pain
• Dyspepsia
• Flatulence
• Nasopharyngitis (inflammation of the throat and nasal passages)